PCI Biotech Holding ASA (STU:4QG) Operating Cash Flow per Share : €-0.08 (TTM As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

What is PCI Biotech Holding ASA Operating Cash Flow per Share?

PCI Biotech Holding ASA's operating cash flow per share for the three months ended in Jun. 2023 was €-0.01. PCI Biotech Holding ASA's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.08.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 42.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 21.10% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 8.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for PCI Biotech Holding ASA's Operating Cash Flow per Share or its related term are showing as below:

STU:4QG' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -33.1 Med: -2.9 Max: 42.2
Current: 42.2

During the past 13 years, PCI Biotech Holding ASA's highest 3-Year average Operating Cash Flow per Share Growth Rate was 42.20% per year. The lowest was -33.10% per year. And the median was -2.90% per year.

STU:4QG's 3-Year OCF Growth Rate is ranked better than
87.3% of 1236 companies
in the Biotechnology industry
Industry Median: 3.35 vs STU:4QG: 42.20

PCI Biotech Holding ASA Operating Cash Flow per Share Historical Data

The historical data trend for PCI Biotech Holding ASA's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PCI Biotech Holding ASA Operating Cash Flow per Share Chart

PCI Biotech Holding ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.29

-0.20

-0.18

-0.15

-0.04

PCI Biotech Holding ASA Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.02	-0.03	-0.01	-0.01	-

Competitive Comparison of PCI Biotech Holding ASA's Operating Cash Flow per Share

For the Biotechnology subindustry, PCI Biotech Holding ASA's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PCI Biotech Holding ASA's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PCI Biotech Holding ASA's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where PCI Biotech Holding ASA's Price-to-Operating-Cash-Flow falls into.

PCI Biotech Holding ASA Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

PCI Biotech Holding ASA's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-1.301	/	37.326
	=	-0.03

PCI Biotech Holding ASA's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Jun. 2023 )	=	Cash Flow from Operations (Q: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2023 )
	=	-0.469	/	37.326
	=	-0.01

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.08

PCI Biotech Holding ASA Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of PCI Biotech Holding ASA's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

PCI Biotech Holding ASA (STU:4QG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PCI Biotech Holding ASA (STU:4QG) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

PCIB:Norway 4QG:Germany

Address

Ullernchausseen 64, Oslo, NOR, N-0379

Website

https://www.pcibiotech.com

PCI Biotech Holding ASA is a biopharmaceutical company. It focuses on developing and commercializing therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The PCI technology works by inducing light-triggered endosomal release. PCI is applied to three distinct anticancer paradigms; fimaCHEM which is an enhancement of chemotherapeutics for localized treatment of cancer, fimaVACC which is T-cell induction technology for therapeutic vaccination, and fimaNAc which is nucleic acid therapeutics delivery. Its therapeutic product candidate is the photosensitizer fimaporfin (Amphinex) which can unlock the intracellular capsules where active compounds are trapped.

PCI Biotech Holding ASA (STU:4QG) Headlines

No Headlines